For GOP, a favorable decision might be the classic "win the battle, lose the war" scenario.
TPP rules would foreclose cost-saving reforms for biotech drugs and Medicare Part D.
If there are indeed medical benefits to marijuana, the FDA should review it just like any other drug.
With "The Campaign to Change Direction," the first lady is helping to remove the stigma of mental illness.
Supposedly dead bills can always rise again, such as proposed changes to Medicare Part D.
The president will win no matter how the Supreme Court decides, and ObamaCare will go down in history as a great legacy achievement.
Washington is all atwitter over the upcoming Supreme Court decision in King v. Burwell.
Keeping workers healthy is good business sense, but on-site clinics might not be the answer.
There is no reason why television doctors should be excluded from disclosure requirements.
From its inception, the ACA's Independent Payment Advisory Board has generated controversy.